Emerging Infectious Diseases (Feb 2014)

Anncaliia algerae Microsporidial Myositis

  • Matthew R. Watts,
  • Renee C.F. Chan,
  • Elaine Y.L. Cheong,
  • Susan Brammah,
  • Kate R. Clezy,
  • Chiwai Tong,
  • Deborah Marriott,
  • Cameron E. Webb,
  • Bobby Chacko,
  • Vivienne Tobias,
  • Alexander C. Outhred,
  • Andrew S. Field,
  • Michael V. Prowse,
  • James V. Bertouch,
  • Damien Stark,
  • Stephen W. Reddel

DOI
https://doi.org/10.3201/eid2002.131126
Journal volume & issue
Vol. 20, no. 2
pp. 185 – 191

Abstract

Read online

The insect microsporidian Anncaliia algerae was first described in 2004 as a cause of fatal myositis in an immunosuppressed person from Pennsylvania, USA. Two cases were subsequently reported, and we detail 2 additional cases, including the only nonfatal case. We reviewed all 5 case histories with respect to clinical characteristics, diagnosis, and management and summarized organism life cycle and epidemiology. Before infection, all case-patients were using immunosuppressive medications for rheumatoid arthritis or solid-organ transplantation. Four of the 5 case-patients were from Australia. All diagnoses were confirmed by skeletal muscle biopsy; however, peripheral nerves and other tissues may be infected. The surviving patient received albendazole and had a reduction of immunosuppressive medications and measures to prevent complications. Although insects are the natural hosts for A. algerae, human contact with water contaminated by spores may be a mode of transmission. A. algerae has emerged as a cause of myositis, particularly in coastal Australia. Download MP3 Length: 1:30

Keywords